BACKGROUND: Numerous methods have been reported for the determination of artemether (ARM) and its metabolite dihydroartemisinin (DHA) in plasma. However, stability issues in patient plasma have not received enough attention. RESULTS: An LC-MS/MS method for simultaneous determination of ARM and DHA in human plasma (K3EDTA) turned out to be problematic: ARM and DHA were degraded partially or completely in some patient plasma samples as indicated by the stable isotope-labeled internal standards. We postulated iron II (Fe(2+)) in hemoglobin or its derived products from malaria patients causes degradation of the drugs, and found that hydrogen peroxide (H2O2) protected the drugs from degradation. Acidifying plasma increased recovery of ARM significantly. Using only 50 µl of plasma sample, the method has a LLOQ at 0.5 ng/ml for both ARM and DHA. CONCLUSION: H2O2 is a stabilizing agent for artemisinin derivatives. The modified method is reliable and sensitive.
BACKGROUND: Numerous methods have been reported for the determination of artemether (ARM) and its metabolite dihydroartemisinin (DHA) in plasma. However, stability issues in patient plasma have not received enough attention. RESULTS: An LC-MS/MS method for simultaneous determination of ARM and DHA in human plasma (K3EDTA) turned out to be problematic: ARM and DHA were degraded partially or completely in some patient plasma samples as indicated by the stable isotope-labeled internal standards. We postulated iron II (Fe(2+)) in hemoglobin or its derived products from malariapatients causes degradation of the drugs, and found that hydrogen peroxide (H2O2) protected the drugs from degradation. Acidifying plasma increased recovery of ARM significantly. Using only 50 µl of plasma sample, the method has a LLOQ at 0.5 ng/ml for both ARM and DHA. CONCLUSION:H2O2is a stabilizing agent for artemisinin derivatives. The modified method is reliable and sensitive.
Authors: Daniel Blessborn; Karl Sköld; David Zeeberg; Karnrawee Kaewkhao; Olof Sköld; Martin Ahnoff Journal: Bioanalysis Date: 2013-01 Impact factor: 2.681
Authors: N Lindegardh; W Hanpithakpong; B Kamanikom; P Singhasivanon; D Socheat; P Yi; A M Dondorp; R McGready; F Nosten; N J White; N P J Day Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2008-10-18 Impact factor: 3.205
Authors: E M Hodel; B Zanolari; T Mercier; J Biollaz; J Keiser; P Olliaro; B Genton; L A Decosterd Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2009-02-11 Impact factor: 3.205
Authors: R Kajubi; L Huang; P Jagannathan; N Chamankhah; M Were; T Ruel; C A Koss; A Kakuru; N Mwebaza; M Kamya; D Havlir; G Dorsey; P J Rosenthal; F T Aweeka Journal: Clin Pharmacol Ther Date: 2017-05-30 Impact factor: 6.875
Authors: Sunil Parikh; Fatai Fehintola; Liusheng Huang; Alexander Olson; Waheed A Adedeji; Kristin M Darin; Gene D Morse; Robert L Murphy; Babafemi O Taiwo; Olusegun O Akinyinka; Isaac F Adewole; Francesca T Aweeka; Kimberly K Scarsi Journal: Antimicrob Agents Chemother Date: 2015-09-21 Impact factor: 5.191
Authors: Liusheng Huang; Vincent Carey; Jane C Lindsey; Florence Marzan; David Gingrich; Bobbie Graham; Linda Barlow-Mosha; Phionah K Ssemambo; Portia Kamthunzi; Sharon Nachman; Sunil Parikh; Francesca T Aweeka Journal: PLoS One Date: 2017-10-24 Impact factor: 3.240